Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 3/2019

01-12-2019 | Breast Cancer | Editorial

BCRT: a brief valedictory

Author: Marc Lippman

Published in: Breast Cancer Research and Treatment | Issue 3/2019

Login to get access

Excerpt

For nearly 28 years, I have served as the Editor-in-Chief of Breast Cancer Research and Treatment. I had previously been an associate editor, and when Bill McGuire tragically died at the height of his career, I was asked to assume his role. Now, nearly 3 decades later Dr. William Gradishar will become the new Editor-in-Chief. …
Metadata
Title
BCRT: a brief valedictory
Author
Marc Lippman
Publication date
01-12-2019
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 3/2019
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-019-05475-7

Other articles of this Issue 3/2019

Breast Cancer Research and Treatment 3/2019 Go to the issue

Clinical trial

Chemotherapy-induced peripheral neuropathy (CIPN) in breast cancer survivors: a comparison of patient-reported outcomes and quantitative sensory testing

Epidemiology

The impact of health symptoms on health-related quality of life in early-stage breast cancer survivors

Preclinical study

CDC20 expression in oestrogen receptor positive breast cancer predicts poor prognosis and lack of response to endocrine therapy

Clinical trial

Prophylactic acupuncture treatment during chemotherapy with breast cancer: a randomized pragmatic trial with a retrospective nested qualitative study

Clinical trial

Cost-utility, cost-effectiveness, and budget impact of Internet-based cognitive behavioral therapy for breast cancer survivors with treatment-induced menopausal symptoms

Epidemiology

Optimal treatment of breast cancer in women older than 75 years: a Korea Breast Cancer Registry analysis
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits